| Primary information |
|---|
| ID | antitb_1874 |
| Peptide Name | Buforin II (5–21) |
| Sequence | RAGLQFPVGRVHRLLRK |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 17 |
| Chirality | L |
| Nature | Cationic |
| Source | Natural |
| Origin | Peptide from the stomach tissue of Bufo bufo garagrizans |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis H37Rv (ATCC 27294) |
| Inhibition Concentartion | MIC >300 μM |
| In vitro/In vivo | In vitro |
| Cell Line | RBC |
| Inhibition Concentartion | NA |
| Cytotoxicity | 50% hemolysis at >300 μM |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | Antibacterial (Streptococcus pneumoniae) |
| Pubmed ID | 28314993 |
| Year of Publication | 2017 |
| 3-D Structure | NA |